Results: 129 Indonesian urologists participated in this study. Most of them faced more than 20 OAB cases per year with the most common type was OAB without incontinence or dry OAB (57.4%). Most urologists (34.1%) ordered at least three diagnostic tools to determine OAB. They were bladder diary, urinalysis and scoring system. The most used scoring system (48.9%) was the overactive bladder symptoms score (OABSS). Thirty-five point seven percents (35.7%) of urologists used antimuscarinic and behavioral therapy as initial therapy. Solifenacin 5 mg/day was the most common antimuscarinic prescribed as the first line therapy (48%). Most common items commonly evaluated for followup: symptoms (96.9%), bladder diary (72.9%); and drug's side effect (58.1%). When initial therapy had failed, most of the urologists (54.3%) chose to increase the dose of antimuscarinic. None of them chose bladder botulinum toxin injection as their additional therapy. OAB occurs in millions of people around the world. Its prevalence increases with age. 5 However, many OAB patients are still underdiagnosed and undertreated. This is due to patients embarrassment to consult to their physician and the belief that this condition is related to the aging process. Belief of treatment unavailability might be another factor. 5 OAB with incontinence is termed as wet OAB, while dry OAB patients do not complain about incontinence. 6 According to epidemiological research from North America, the prevalence of OAB in women is 16.9%. It is increased to 30.9% in women above 65 year-old. 1 In European countries, 16.6% men and women above 40 year-old suffer from OAB.
Conclusion
1 A more recent study in Canada and several European countries showed that as many as 11.8% of men and women over 18 years old have a complaint suggestive of OAB. 7 A study in Indonesia showed that 4.1% and 1.8% of people from children to elderly have wet OAB and dry OAB, respectively. 8 Overactive bladder is a syndrome that is not life threatening, therefore, often ignored by patients and physicians. The effect of OAB in daily and quality of life is however very substantial.
9
Geriatric women tend to suffer from wet OAB. 10 A survey held by Department of Internal Medicine Cipto Mangunkusumo Hospital to 208 geriatric population in Jakarta found the incidence of wet OAB was 32.3%.
11
The aim of this study was to review the management of OAB by Indonesian urologists. The results of this study are very important in giving us an overview of how Indonesian urologists are treating OAB patients.
METHODS
The data was compiled from self-constructed questionnaires which were distributed to Indonesian urologists during Indonesian annual urology scientific meeting on 2012 in Jakarta. The questionnaire comprises of nine questions containing diagnostic and treatment options of OAB patients. The participants of the meeting were 231 persons consisted of 144 urologists and 87 general practitioners. On that time, the member of Indonesian Urological Association was 241 persons. According to Health Research Ethics Committee, Faculty of Medicine Universitas Indonesia, Jakarta, this study did not require ethical approval.
RESULTS
One hundred and twenty nine Indonesian urologists participated in this study from total of 241 urologists in Indonesia. Most urologists worked in governmental and teaching hospital (38%), non-governmental and non-teaching hospital (34.9%), and governmental hospital (27.1%). The amount and type of OAB faced by Indonesian urologists are shown in table 1. Diagnostic tool(s) chosen by Indonesia urologists to diagnose OAB are described in table 2.
Most of Indonesia urologists (76%) used bladder diary to diagnose OAB, followed by scoring system (68.2%) and urinalysis examination When patients with OAB came to the office for follow-up, severity of patients' symptoms whether they becoming better or worse were the most commonly evaluated (96.9%), followed by bladder diary (72.9%).
The types of next additional therapy when initial therapy had failed can be seen in table 6.
When the initial therapy had failed, most of the urologists (54.3%) chose to increasing the dose of antimuscarinic, followed by switch to another antimuscarinic (38%) and combine two types of antimuscarinic (34.1%). No body chose bladder botulinumtoxin injection as their additional therapy.
DISCUSSION
The symptoms of OAB have several causes and multifactorial. Mechanism of voiding involves the nervous systemand anatomy of the lower urinary tract. Any abnormalities of these organs can be the cause of OAB. The symptoms are usually linked to involuntary bladder contractions. 12 When these symptoms occur without any other abnormality of the urinary tract and bothersome to the patient, then diagnoses of OAB can be made.
2,3
Treatment of OAB requires a proper and good diagnostic evaluation. A careful history taking of the genitourinary disorders and other diseases should be obtained from each patient. The physician should perform diagnostic steps to diagnose OAB and exclude other diseases. Beside proper history taking, a good physical examination and laboratory examination i.e. urinalysis are also important. 2 Abdomen, genitourinary, and rectal examination as well as assessment of the lower extremities are pivotal for diagnosis. 2, 3, 12 Urinalysis is useful to exclude hematuria, leukosituria and glucose in the urine. 2, 3, 12 Some additional investigations are needed to establish diagnosis, design a proper treatment and exclude other diseases. Based on clinical judgement, post-void residual urine and urine culture may be obtained. Bladder diary and symptom questionnaires are tools to aid the physicians in assessing complaints more objectively. 2, 3 In uncomplicated patients, invasive examination such as urodynamics, cystoscopy and ultrasound of kidney and bladder are not recommended as the initial management. 2 This study showed that most of Indonesian urologists ordered bladder diary, urinalysis examination, and scoring system as their procedures to determine OAB. This finding was similar and suitable with previous studies and guidelines. 2, 10, 13 International prostate symptom score (IPSS) is a symptom score used for benign prostatic obstruction (BPO).
14 It includes 7 questions on storage and voiding symptoms.
14 OABSS was first developed by Homma, et al 15 using the Japanese language. It was then validated among Japanese patients and has been accepted in several countries. [15] [16] [17] [18] OABSS is a self administered questionnaire based on questions on symptoms of OAB: urgency, incontinence, frequency, and nocturia.
15
Another questionnaire, called OAB-V8 was invented by Coyne, et al. 19 This questionnaire contains 8 items of questions related to bother of the symptoms of OAB (frequency, urgency, nocturia, and incontinence).
14 OAB-V8 has been widely use and translated into many languages. 20 Indonesian urologists use these three different scoring systems. Most of them use OABSS and IPSS as their scoring systems to determine patients with OAB.
Successful OAB treatment relies on proper evaluation and follow-up. The etiology of OAB is multifactorial thus lifestyle and behavioral modification, physical therapy and pharmacological treatment are mandatory. Behavioral and lifestyle modification are recommended by several studies as the first line therapy for OAB. 2, 3, 12 There are two principles for this therapy, one is modifying the voiding pattern using delayed voiding method and bladder training. The other is to strengthen the pelvic floor muscle to manage urgency and to prevent incontinence. 2 It is important to educate and give information to patients about diet (types and amount of beverages, food and timing of consumption). 12 Each treatment for each patient must be tailored accordingly depending on several factors such as age, level of education, and availability of caregiver. 3 American Urological Association/ Society of Urodynamics, Female Pelvic Medicine and Urogenital Reconstruction (AUA/SUFU) have recommended that combination of behavioral therapies and antimuscarinic as the first line treatment. Several literatures reported that this combination can improve outcomes compared to each treatment alone. 2 The same recommendation also issued by Indonesian Continence Association. 10 Several types of drugs have been investigated for the treatment of OAB.
12 AUA/ SUFU guidelines recommended oral antimuscarinic as secondline therapy. 2 Every single antimuscarinic has its own side effects. The most common side effect is dry mouth. Other side effects are blurry vision, gastroesophageal reflux, constipation, urinary retention, and cognitive impairment. Cognitive impairment is one of the primary concern in elderly population since dementia commonly occurs in this group of people. 12 Antimuscarinic drugs are efficacious, safe, and well-tolerated treatments that improve quality of life. 21 Many studies with the aim to compare among antimuscarinic drugs had been published with various results. 5, 12, 22, 23 Most Indonesian urologists (98.5%) used antimuscarinic as their initial therapy to treat OAB. This result was suitable with the guideline that has been published. 2, 10, 13 Follow-up is useful in assessing treatment compliance, symptom improvement and side effects of the drugs. Based on those information, alternative treatments can be prescribed for patients with minimal symptom improvement and disturbing side effects of the drugs.
2
Offering follow-up and alternative treatments to the patients have been recommended by the guidelines. 2, 10 All of the Indonesian urologists perform follow-up for the patients and almost all of them assess the symptom improvement. This finding was in line with the guidelines.
2,10
AUA/SUFU guideline recommends antimuscarinic dose modification or switching to a different antimuscarinic in patients with minimal symptom improvement and intolerable side effects of the drugs. 2 One antimuscarinic drug has not been proven superior to other drugs for improvement in symptoms and quality of life. 13 Recent study showed that most of Indonesian urologists choose to modify the antimuscarinic dose or to switch the type of antimuscarinic once a patient had failed the initial therapy. This finding was suitable with the guideline. 2 OnabotulinumtoxinA and/or neuromodulation may be an other treatment option for the carefully selected patients who has failed behavioral and antimuscarinic therapies. 2, 10 Previous studies reported the efficacy of peripheral tibial nerve stimulation (PTNS) in the treatment of incontinence, frequency, nocturia, and the improvement of quality of life.
2,24-27 Studies on sacral neuromodulation demonstrated that all improvement of quality of life and subjective symptoms. 2, [28] [29] [30] [31] The FDA has already approved injection of intradetrusor onabotulinumtoxinA (100U) as a third-line treatment in nonneurogenic OAB patients. 2 Indwelling catheters remain the last treatment option and are not recommended for OAB. Patients with refractory and complicated OAB can be offered augmentation of the bladder or urinary diversion although these treatments are very rare. 2, 10, 12, 13 A few of Indonesian urologists offered neuromodulation and augmentation of the bladder once they failed the therapy. None of them offer the use of onabotulinumtoxinA to a patient probably due to the regiment has not been circulating in Indonesia.
In conclusion, OAB is a frequent disorder which remains a challenge for urologists. The management of patients with OAB by Indonesian urologists has been suitable with the previous studies and guidelines.
